Stem Cells Cloned from Patient with Diabetes
the MPR take:
Patients with diabetes may one day benefit from stem cell therapy, as research published in the journal Nature describes the first insulin-producing cells containing the DNA of a 32-year-old woman with type 1 diabetes. In this cloning process, known as nuclear transfer, a donated ovum with all DNA removed had the woman's adult cells inserted and reprogrammed to produce insulin cells. This could lead to diabetic patients being able to produce their own cells that make insulin to replace their non-functioning cells. There are ethical concerns surrounding nuclear transfer, particularly regarding recruitment and compensation for egg donors needed for stem cell research.
READ FULL ARTICLE From Time